TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
474,477
|
440,283
|
445,873 |
Earnings before taxes |
15,463
|
14,341
|
14,309 |
Total assets |
117,324
|
115,803
|
137,489 |
Current assets |
114,939
|
113,054
|
132,889 |
Current liabilities |
79,435
|
78,647
|
102,026 |
Equity capital |
37,889
|
36,946
|
34,778 |
- share capital |
10,000
![]() |
10,000
![]() |
10,000 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
31.9%
|
25.3% |
Turnover per employee |
6,326
|
5,870
|
5,945 |
Profit as a percentage of turnover |
3.3%
![]() |
3.3%
|
3.2% |
Return on assets (ROA) | |||
Current ratio |
144.7%
|
143.7%
|
130.3% |
Return on equity (ROE) |
40.8%
|
38.8%
|
41.1% |
Change turnover |
34,194
|
-5,590
|
4,171 |
Change turnover % |
8%
|
-1%
|
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.